Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
1.660
-0.190 (-10.27%)
At close: Apr 1, 2025, 4:00 PM
1.703
+0.042 (2.56%)
After-hours: Apr 1, 2025, 7:59 PM EDT

Evaxion Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Market Capitalization
102643102--
Upgrade
Market Cap Growth
-24.74%-39.34%-58.12%---
Upgrade
Enterprise Value
4232794--
Upgrade
Last Close Price
1.6634.2888.75221.00--
Upgrade
PS Ratio
0.53355.98----
Upgrade
PB Ratio
-6.30-5.495.163.15--
Upgrade
P/TBV Ratio
234.35-5.163.16--
Upgrade
EV/Sales Ratio
1.33320.29----
Upgrade
Debt / Equity Ratio
--2.301.240.110.000.00
Upgrade
Asset Turnover
0.240.00----
Upgrade
Quick Ratio
-0.943.857.881.636.09
Upgrade
Current Ratio
-1.184.518.032.226.36
Upgrade
Return on Equity (ROE)
--1238.11%-113.74%-124.29%-183.15%-265.57%
Upgrade
Return on Assets (ROA)
-69.45%-79.47%-50.78%-61.95%-89.85%-69.29%
Upgrade
Return on Capital (ROIC)
-246.40%-112.34%-57.75%-74.78%-125.85%-79.25%
Upgrade
Earnings Yield
-101.58%-85.14%-54.08%-23.98%--
Upgrade
FCF Yield
-68.41%-60.85%-22.71%--
Upgrade
Buyback Yield / Dilution
-78.19%-15.64%-21.27%-26.29%-11.10%-7.55%
Upgrade
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q